These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15213710)

  • 1. Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it?
    Verburg FA; Lips CJ; Lentjes EG; de Klerk JM
    Br J Cancer; 2004 Jul; 91(2):200-4. PubMed ID: 15213710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
    Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer.
    Grammatopoulos D; Elliott Y; Smith SC; Brown I; Grieve RJ; Hillhouse EW; Levine MA; Ringel MD
    Mol Pathol; 2003 Jun; 56(3):162-6. PubMed ID: 12782763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients.
    Savagner F; Rodien P; Reynier P; Rohmer V; Bigorgne JC; Malthiery Y
    J Clin Endocrinol Metab; 2002 Feb; 87(2):635-9. PubMed ID: 11836297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
    Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
    Biscolla RP; Cerutti JM; Maciel RM
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer.
    Eszlinger M; Neumann S; Otto L; Paschke R
    Eur J Endocrinol; 2002 Nov; 147(5):575-82. PubMed ID: 12444888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin.
    Westbury C; Vini L; Fisher C; Harmer C
    Thyroid; 2000 Feb; 10(2):171-6. PubMed ID: 10718555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human thyrotropin stimulation of thyroglobulin in the follow-up of patients with stage I or II differentiated thyroid carcinoma.
    Baskin HJ; Atwood TM; Holcomb LP
    Endocr Pract; 2000; 6(6):430-4. PubMed ID: 11155213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
    Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
    Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum oncofetal fibronectin (onfFN) mRNA in differentiated thyroid carcinoma (DTC): large overlap between disease-free and metastatic patients.
    Sritara C; Charoenphun P; Ponglikitmongkol M; Musikarat S; Utamakul C; Chokesuwattanasakul P; Thakkinstian A
    Asian Pac J Cancer Prev; 2012; 13(8):4203-8. PubMed ID: 23098431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
    Li D; Butt A; Clarke S; Swaminathana R
    Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroglobulin mRNA amplification in peripheral blood of patients with differentiated thyroid carcinoma: what does it really mean?].
    Coelho SM; Vaisman M; de Carvalho DP
    Arq Bras Endocrinol Metabol; 2006 Jun; 50(3):427-35. PubMed ID: 16936982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
    Hocevar M; Auersperg M
    Eur J Surg Oncol; 1998 Dec; 24(6):553-7. PubMed ID: 9870733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
    Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
    Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.